Intensity Therapeutics, Inc. (INTS) earnings
INTS earnings moved a median of -1.42% by the close. Quarterly and annual INTS reports and results, each read against the price at its own news timestamp. Back to the INTS overview →
23 measured INTS earnings events.
Where these INTS earnings landedvs 23 measured INTS earnings reactions
| Middle 50% of INTS earnings reactions | -3.32% to +0.36% |
|---|---|
| Median reaction (to close) | -1.42% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 INTS earnings events with a measured close landed between -3.32% and +0.36%; 26% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q INTENSITY THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +5.06% | -1.90% | |
| Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update | Press release | +5.06% | -1.90% | |
| Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026 | Press release | -0.29% | -0.29% | |
| Form 10-Q INTENSITY THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.72% | |
| Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +0.00% | +0.72% | |
| Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026 | Press release | — | -1.42% | |
| Form 10-Q INTENSITY THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -2.52% | -1.55% | |
| Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | -2.52% | -1.55% | |
| Form 10-K INTENSITY THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.24% | |
| Form 10-Q INTENSITY THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +2.02% | -7.12% | |
| Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +2.02% | -7.12% | |
| Form 10-Q INTENSITY THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +1.19% | -0.04% | |
| Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | +1.19% | -0.04% | |
| Form 10-Q INTENSITY THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -0.34% | -4.16% | |
| Intensity Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | -0.34% | -4.16% | |
| Form 10-K INTENSITY THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +11.74% | +8.92% | |
| Form 10-Q INTENSITY THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | — | +5.48% | |
| Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | — | +5.48% | |
| Form 10-Q INTENSITY THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -4.25% | -3.40% | |
| Intensity Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | -4.25% | -3.40% | |
| Form 10-Q INTENSITY THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +1.24% | +0.00% | |
| Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +1.24% | +0.00% | |
| Form 10-K INTENSITY THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +16.46% |
Keep exploring
More INTS: analyst actions → · SEC filings → · INTS overview →